• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    36.85 Up 0.88(2.45%) Dec 26, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development16,014  7,998  7,808  
    Selling General and Administrative6,744  2,206  2,357  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (22,759) (10,204) (10,164)
    Income from Continuing Operations
    Total Other Income/Expenses Net(2,393)(51)(76)
    Earnings Before Interest And Taxes(25,152)(10,255)(10,240)
    Interest Expense937  1,487  577  
    Income Before Tax(26,088)(11,742)(10,817)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(26,088)(11,742)(10,817)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (26,088) (11,742) (10,817)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (26,088) (11,742) (10,817)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.